These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33360082)

  • 1. Synthetic approaches to unsymmetrical 2,5-disubstituted 1,3,4-oxadiazoles and their MAO-B inhibitory activity. A review.
    Karabelyov V; Kondeva-Burdina M; Angelova VT
    Bioorg Med Chem; 2021 Jan; 29():115888. PubMed ID: 33360082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel 2,5-disubstituted-1,3,4-oxadiazole derivatives as MAO-B inhibitors: Synthesis, biological evaluation and molecular modeling studies.
    Tok F; Uğraş Z; Sağlık BN; Özkay Y; Kaplancıklı ZA; Koçyiğit-Kaymakçıoğlu B
    Bioorg Chem; 2021 Jul; 112():104917. PubMed ID: 33932769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug design, synthesis, in vitro and in silico evaluation of selective monoaminoxidase B inhibitors based on 3-acetyl-2-dichlorophenyl-5-aryl-2,3-dihydro-1,3,4-oxadiazole chemical scaffold.
    Distinto S; Meleddu R; Yanez M; Cirilli R; Bianco G; Sanna ML; Arridu A; Cossu P; Cottiglia F; Faggi C; Ortuso F; Alcaro S; Maccioni E
    Eur J Med Chem; 2016 Jan; 108():542-552. PubMed ID: 26717204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,3,4-Oxadiazol-2-ylbenzenesulfonamides as privileged structures for the inhibition of monoamine oxidase B.
    Shetnev A; Shlenev R; Efimova J; Ivanovskii S; Tarasov A; Petzer A; Petzer JP
    Bioorg Med Chem Lett; 2019 Nov; 29(21):126677. PubMed ID: 31537422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,3,4-Oxadiazole-3(2H)-carboxamide derivatives as potential novel class of monoamine oxidase (MAO) inhibitors: synthesis, evaluation, and role of urea moiety.
    Ke S; Li Z; Qian X
    Bioorg Med Chem; 2008 Aug; 16(16):7565-72. PubMed ID: 18678501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-Acetyl-2,5-diaryl-2,3-dihydro-1,3,4-oxadiazoles: a new scaffold for the selective inhibition of monoamine oxidase B.
    Maccioni E; Alcaro S; Cirilli R; Vigo S; Cardia MC; Sanna ML; Meleddu R; Yanez M; Costa G; Casu L; Matyus P; Distinto S
    J Med Chem; 2011 Sep; 54(18):6394-8. PubMed ID: 21777011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible and irreversible small molecule inhibitors of monoamine oxidase B (MAO-B) investigated by biophysical techniques.
    Rojas RJ; Edmondson DE; Almos T; Scott R; Massari ME
    Bioorg Med Chem; 2015 Feb; 23(4):770-8. PubMed ID: 25600407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of biaryl derivatives for structural characterization of selective monoamine oxidase B inhibitors toward Parkinson's disease therapy.
    Yeon SK; Choi JW; Park JH; Lee YR; Kim HJ; Shin SJ; Jang BK; Kim S; Bahn YS; Han G; Lee YS; Pae AN; Park KD
    Bioorg Med Chem; 2018 Jan; 26(1):232-244. PubMed ID: 29198609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, monoamine oxidase inhibitory activity and computational study of novel isoxazole derivatives as potential antiparkinson agents.
    Agrawal N; Mishra P
    Comput Biol Chem; 2019 Apr; 79():63-72. PubMed ID: 30731360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of 2-substituted 4(3H)-quinazolinone thioether derivatives as monoamine oxidase inhibitors.
    Qhobosheane MA; Petzer A; Petzer JP; Legoabe LJ
    Bioorg Med Chem; 2018 Nov; 26(20):5531-5537. PubMed ID: 30279044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic, Molecular and Computational Aspects of Novel Monoamine Oxidase (MAO) Inhibitors.
    Ramesh M; Dokurugu YM; Thompson MD; Soliman ME
    Comb Chem High Throughput Screen; 2017; 20(6):492-509. PubMed ID: 28294055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of monoamine oxidase by indole and benzofuran derivatives.
    Prins LH; Petzer JP; Malan SF
    Eur J Med Chem; 2010 Oct; 45(10):4458-66. PubMed ID: 20674099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel approaches to the discovery of selective human monoamine oxidase-B inhibitors: is there room for improvement?
    Guglielmi P; Carradori S; Ammazzalorso A; Secci D
    Expert Opin Drug Discov; 2019 Oct; 14(10):995-1035. PubMed ID: 31268358
    [No Abstract]   [Full Text] [Related]  

  • 14. Pyrimido[1,2-b]indazole derivatives: Selective inhibitors of human monoamine oxidase B with neuroprotective activity.
    Jismy B; El Qami A; Pišlar A; Frlan R; Kos J; Gobec S; Knez D; Abarbri M
    Eur J Med Chem; 2021 Jan; 209():112911. PubMed ID: 33071056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Exploration of Synthetic Chromones as Selective MAO-B Inhibitors: A Mini Review.
    Mathew B; Mathew GE; Petzer JP; Petzer A
    Comb Chem High Throughput Screen; 2017; 20(6):522-532. PubMed ID: 28245770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and characterization of novel radiofluorinated probes for positron emission tomography imaging of monoamine oxidase B.
    Yoshimoto M; Hirata M; Kagawa S; Magata Y; Ohmomo Y; Temma T
    J Labelled Comp Radiopharm; 2019 Jul; 62(9):580-587. PubMed ID: 31215665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of monoamine oxidase by selected C6-substituted chromone derivatives.
    Legoabe LJ; Petzer A; Petzer JP
    Eur J Med Chem; 2012 Mar; 49():343-53. PubMed ID: 22309913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of novel chalcones as potent selective monoamine oxidase-B inhibitors.
    Hammuda A; Shalaby R; Rovida S; Edmondson DE; Binda C; Khalil A
    Eur J Med Chem; 2016 May; 114():162-9. PubMed ID: 26974383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The synthesis and evaluation of sesamol and benzodioxane derivatives as inhibitors of monoamine oxidase.
    Engelbrecht I; Petzer JP; Petzer A
    Bioorg Med Chem Lett; 2015 May; 25(9):1896-900. PubMed ID: 25857942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-Coumaranone derivatives as inhibitors of monoamine oxidase.
    Van Dyk AS; Petzer JP; Petzer A; Legoabe LJ
    Drug Des Devel Ther; 2015; 9():5479-89. PubMed ID: 26491258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.